• Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

    Source: Buzz FX / 10 Feb 2025 10:46:10   America/Chicago


    Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat February 10, 2025 Share Link copied to clipboard. Arcutis Biotherapeutics, Inc.
    Read more...
Share on,